KFDA approves amlodipine adipate

Published: 2004-10-08 06:47:00

Updated: 2004-10-08 06:47:00

CJ Corporation said its new amlodipine adipate (brandname: Amlosta tablet) has been approved for marketing by the Korea Food and Drug Administration, based on the results of local Phase III clinical trials involving 211 subjects in 15 general hospitals including Seoul National University.

The ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK